HLB Co., Ltd. (028300.KQ) KOE

46,550.00

-50(-0.11%)

Updated at December 24 03:30PM

Currency In KRW

HLB Co., Ltd.

Address

216-53, Dangwol-ro

Ulsan, 135-816

Korea, Republic of

Phone

82 5 2240 3500

Sector

Healthcare

Industry

Biotechnology

Employees

160

First IPO Date

December 24, 2008

Key Executives

NameTitlePayYear Born
Baek Yoon KiChief Executive Officer & Executive Director01963
Jaehyung ParkExecutive Director01966
Kim Dong GunExecutive Director01962
Yonghae HanExecutive Director0N/A
Im Chang YoonVice Chairman01966
Sung-Cheol KimHead of Bio Department01964
Yang-Gon JinExecutive Chairman01966

Description

HLB Co., Ltd. manufactures pharmaceutical products, and builds ships. It manufactures and sells various types of lifeboats for marine plants, drill ships, and cruise vessels in South Korea. The company offers conventional type lifeboats, free fall type lifeboats, and rescue boats. It also provides marine and yacht engines; hooks; RIB, patrol, fishing, aluminum, and leisure boats; fishery inspection ships; and safety goods, as well as lifeboat and davit inspection and repair services, service engineering training, and spare parts for lifeboats and davits. In addition, the company develops Riboseranib, a targeted anti-cancer agent; and Apilia that is used for the treatment for ovarian cancer. HLB Co., Ltd. was founded in 1975 and is headquartered in Ulsan, South Korea.